Your browser doesn't support javascript.
loading
TGF-ß-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.
Hesler, Rachel A; Huang, Jennifer J; Starr, Mark D; Treboschi, Victoria M; Bernanke, Alyssa G; Nixon, Andrew B; McCall, Shannon J; White, Rebekah R; Blobe, Gerard C.
Afiliação
  • Hesler RA; Department of Pharmacology and Cancer Biology.
  • Huang JJ; Department of Pharmacology and Cancer Biology.
  • Starr MD; Division of Medical Oncology, Department of Medicine.
  • Treboschi VM; Division of Medical Oncology, Department of Medicine.
  • Bernanke AG; Division of Medical Oncology, Department of Medicine.
  • Nixon AB; Division of Medical Oncology, Department of Medicine.
  • McCall SJ; Department of Pathology and.
  • White RR; Department of Surgery, Duke University, B354 LSRC Research Drive , Box 91004, Durham, NC 27708 , USA.
  • Blobe GC; Department of Pharmacology and Cancer Biology.
Carcinogenesis ; 37(11): 1041-1051, 2016 11 01.
Article em En | MEDLINE | ID: mdl-27604902

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Proteínas de Membrana Transportadoras / Carcinoma Ductal Pancreático / Transportador Equilibrativo 1 de Nucleosídeo / Desoxicitidina / Proteína Rica em Cisteína 61 / Antimetabólitos Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Proteínas de Membrana Transportadoras / Carcinoma Ductal Pancreático / Transportador Equilibrativo 1 de Nucleosídeo / Desoxicitidina / Proteína Rica em Cisteína 61 / Antimetabólitos Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article